H3K9 demethylase KDM3A potentiates interferon signaling and macrophage-driven inflammation in atherosclerosis

Macrophages drive atherosclerosis through inflammatory activation programs shaped by metabolic and epigenetic reprogramming. H3K9 methylation enforces heterochromatin states and represses transcription, whereas removal of this histone modification creates transcriptionally permissive chromatin. Here, we identified KDM3A-mediated H3K9 demethylation to enhance chromatin accessibility at interferon (IFN) signaling loci, thereby promoting IFN production and downstream IFN-dependent transcriptional and chemokine responses. In a mouse model of atherosclerosis, hematopoietic Kdm3a deficiency reduces lesion size, necrotic core formation, and neutrophil recruitment. Mechanistically, Kdm3a -deficient macrophages show impaired chemokine secretion and reduced neutrophil recruitment both in vitro and in vivo. In primary human macrophages, KDM3A knockdown suppressed IFN responses; consistently KDM3A-dependent gene signatures were enriched in IFN-inducible macrophages within human atherosclerotic plaques, and computational modeling predicted a shift toward more stable plaque phenotypes upon KDM3A inhibition. Together, these findings establish KDM3A as an epigenetic regulator that sustains IFN-driven macrophage activation and promotes progression of atherosclerosis, nominating KDM3A as a potential target for selectively modulating IFN-dependent inflammation.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2026-11-13
DOI
https://doi.org/10.1126/sciadv.aei2659
Primary Topic
Atherosclerosis and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

H3K9 demethylase KDM3A potentiates interferon signaling and macrophage-driven inflammation in atherosclerosis

Koen H.M. Prange, Tom T. P. Seijkens, Marion J. Gijbels, Saskia van der Velden et al.
2 links
Science Advances
Atherosclerosis and Cardiovascular Diseases
article

H3K9 demethylase KDM3A potentiates interferon signaling and macrophage-driven inflammation in atherosclerosis

Koen H.M. Prange, Tom T. P. Seijkens, Marion J. Gijbels, Saskia van der Velden, Ricky Siebeler, Menno P.J. de Winther, Marten A. Hoeksema, Guillermo R. Griffith, Esther Lutgens, Kaylin C.A. Palm, Michal Mokrý, Annette E. Neele, Tatyana Kuznetsova, Marieke C.S. Boshuizen, Hung‐Jen Chen, Cindy P. A. A. van Roomen
article en

Abstract

Macrophages drive atherosclerosis through inflammatory activation programs shaped by metabolic and epigenetic reprogramming. H3K9 methylation enforces heterochromatin states and represses transcription, whereas removal of this histone modification creates transcriptionally permissive chromatin. Here, we identified KDM3A-mediated H3K9 demethylation to enhance chromatin accessibility at interferon (IFN) signaling loci, thereby promoting IFN production and downstream IFN-dependent transcriptional and chemokine responses. In a mouse model of atherosclerosis, hematopoietic Kdm3a deficiency reduces lesion size, necrotic core formation, and neutrophil recruitment. Mechanistically, Kdm3a -deficient macrophages show impaired chemokine secretion and reduced neutrophil recruitment both in vitro and in vivo. In primary human macrophages, KDM3A knockdown suppressed IFN responses; consistently KDM3A-dependent gene signatures were enriched in IFN-inducible macrophages within human atherosclerotic plaques, and computational modeling predicted a shift toward more stable plaque phenotypes upon KDM3A inhibition. Together, these findings establish KDM3A as an epigenetic regulator that sustains IFN-driven macrophage activation and promotes progression of atherosclerosis, nominating KDM3A as a potential target for selectively modulating IFN-dependent inflammation.

Science AdvancesVol. 12(46)
Mayo Clinic (US), Amsterdam UMC Location University of Amsterdam (NL), The Netherlands Cancer Institute (NL), University Medical Center Utrecht (NL), Maastricht University (NL), Amsterdam University Medical Centers (NL), Amsterdam institute for Immunology and Infectious Diseases (NL), Amsterdam Gastroenterology Endocrinology Metabolism (NL), Amsterdam Cardiovascular Sciences (NL), University of Amsterdam (NL)
ZonMw
Good health and well-being
Atherosclerosis and Cardiovascular Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon